Journal article
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
Cancer cell, Vol.33(4), pp.721-735.e8
04/09/2018
DOI: 10.1016/j.ccell.2018.03.010
PMCID: PMC5966039
PMID: 29622466
Abstract
We analyzed 921 adenocarcinomas of the esophagus, stomach, colon, and rectum to examine shared and distinguishing molecular characteristics of gastrointestinal tract adenocarcinomas (GIACs). Hypermutated tumors were distinct regardless of cancer type and comprised those enriched for insertions/deletions, representing microsatellite instability cases with epigenetic silencing of MLH1 in the context of CpG island methylator phenotype, plus tumors with elevated single-nucleotide variants associated with mutations in POLE. Tumors with chromosomal instability were diverse, with gastroesophageal adenocarcinomas harboring fragmented genomes associated with genomic doubling and distinct mutational signatures. We identified a group of tumors in the colon and rectum lacking hypermutation and aneuploidy termed genome stable and enriched in DNA hypermethylation and mutations in KRAS, SOX9, and PCBP1.
Details
- Title: Subtitle
- Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
- Creators
- Yang Liu - Massachusetts Institute of TechnologyNilay S Sethi - Massachusetts Institute of TechnologyToshinori Hinoue - Van Andel InstituteBarbara G Schneider - Vanderbilt UniversityAndrew D Cherniack - Massachusetts Institute of TechnologyFrancisco Sanchez-Vega - Memorial Sloan Kettering Cancer CenterJose A Seoane - Stanford UniversityFarshad Farshidfar - University of CalgaryReanne Bowlby - BC Cancer AgencyMirazul Islam - Massachusetts Institute of TechnologyJaegil Kim - Massachusetts Institute of TechnologyWalid Chatila - Memorial Sloan Kettering Cancer CenterRehan Akbani - The University of Texas MD Anderson Cancer CenterRupa S Kanchi - The University of Texas MD Anderson Cancer CenterCharles S Rabkin - National Cancer InstituteJoseph E Willis - Case Western Reserve UniversityKenneth K Wang - Mayo ClinicShannon J McCall - Duke UniversityLopa Mishra - George Washington UniversityAkinyemi I Ojesina - University of Alabama at BirminghamSusan Bullman - Harvard UniversityChandra Sekhar Pedamallu - Harvard UniversityAlexander J Lazar - The University of Texas MD Anderson Cancer CenterRyo Sakai - PharmiWeb Solutions, Bracknell RG12 1QB, UK.Vésteinn Thorsson - Institute for Systems BiologyAdam J Bass - Massachusetts Institute of TechnologyPeter W Laird - Van Andel Institute
- Contributors
- Cancer Genome Atlas Research NetworkDeqin Ma (Contributor) - University of Iowa, PathologyMohammed M Milhem (Contributor) - University of Iowa, Internal MedicineAaron D Bossler (Contributor) - University of Iowa, Pathology
- Resource Type
- Journal article
- Publication Details
- Cancer cell, Vol.33(4), pp.721-735.e8
- DOI
- 10.1016/j.ccell.2018.03.010
- PMID
- 29622466
- PMCID
- PMC5966039
- ISSN
- 1535-6108
- eISSN
- 1878-3686
- Grant note
- U24 CA143843 / NCI NIH HHS I01 BX003732 / BLRD VA R01 CA236591 / NCI NIH HHS U24 CA199461 / NCI NIH HHS U24 CA210957 / NCI NIH HHS U54 HG003079 / NHGRI NIH HHS U24 CA210990 / NCI NIH HHS U24 CA210969 / NCI NIH HHS U24 CA143799 / NCI NIH HHS R01 AA023146 / NIAAA NIH HHS R50 CA221675 / NCI NIH HHS U24 CA143867 / NCI NIH HHS U24 CA143858 / NCI NIH HHS U24 CA143882 / NCI NIH HHS P30 CA008748 / NCI NIH HHS U54 HG003067 / NHGRI NIH HHS U24 CA210999 / NCI NIH HHS U24 CA143835 / NCI NIH HHS U54 HG003273 / NHGRI NIH HHS U24 CA143840 / NCI NIH HHS T32 CA009172 / NCI NIH HHS U24 CA144025 / NCI NIH HHS U24 CA143866 / NCI NIH HHS U24 CA210950 / NCI NIH HHS P01 CA098101 / NCI NIH HHS U24 CA210949 / NCI NIH HHS U24 CA143848 / NCI NIH HHS R01 CA163722 / NCI NIH HHS
- Language
- English
- Date published
- 04/09/2018
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Pathology; Internal Medicine
- Record Identifier
- 9984183992002771
Metrics
11 Record Views